GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
I

InnovAge Holding INNV · USD

Health Care · US listing · 🇺🇸 United States

Compare

9.21

+2.68%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2026

Revenue

$989.7m

FY2017FY2026

Net income

−$2.5m

FY2017FY2026

Free cash flow

$50.4m

FY2017FY2026

Shareholders' equity

$235.6m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue$989.7m$853.7m$763.9m$688.1m$698.6m$637.8m$567.2m$465.6m$8.8m$4.8m
Research and development———————$160,000$38,811$77,804
Operating income$66.3m−$29.4m−$23.2m−$49.3m−$4.7m$74.8m$50.9m$39.7m−$5.1m−$5.8m
Net income−$2.5m−$30.3m−$21.3m−$40.7m−$6.5m−$44.0m$26.3m$19.6m−$6.5m−$13.7m
Diluted earnings per share-0.02-0.22-0.16-0.30-0.05-0.320.200.14-2.44-9.41

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets$557.4m$557.2m$579.8m$547.7m$562.9m$538.6m$409.6m$363.2m$9.0m$8.2m
Cash and short-term investments$141.3m$105.9m$102.8m$102.8m$184.4m$203.7m$114.6m$61.2m——
Total liabilities$288.6m$294.3m$280.0m$247.9m$209.1m$180.6m$301.9m$281.8m$8.1m$7.1m
Debt$87.0m$101.1m$113.0m$113.0m$84.8m$82.6m$218.0m$194.8m$1.3m$1.4m
Shareholders' equity$235.6m$235.0m$269.3m$269.3m$332.4m$334.6m$101.0m$74.2m$902,943$1.1m
Shares outstanding137m136m135m136m136m136m133m135m3m1m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations$64.7m$32.9m−$36.9m−$36.9m$27.3m−$7.5m$43.8m$25.9m−$2.4m−$1.8m
Capital spending−$14.3m−$6.3m−$7.9m−$7.9m−$38.2m−$19.5m−$11.8m−$14.5m−$44,636−$45,000
Free cash flow$50.4m$26.6m−$44.8m−$44.8m−$10.9m−$27.1m$32.0m$11.4m−$2.4m−$1.8m
Dividends paid—————−$9.5m−$9.5m−$66.5m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue$262.0m$251.9m$239.7m$236.1m$218.1m$218.1m$209.0m$205.1m
Operating income$16.0m$22.8m$16.1m$8.3m−$10.2m−$9.9m−$12.7m−$4.1m
Net income$8.3m−$29.5m$10.6m$8.0m−$11.4m−$11.4m−$13.2m−$4.9m
Diluted earnings per share0.06-0.210.080.06-0.08-0.08-0.10-0.04
Cash from operations$21.0m$18.0m$21.0m$3.0m$6.0m$24.0m$6.0m−$7.0m
Capital spending−$4.0m−$3.0m−$2.0m−$4.0m−$1.0m−$2.0m−$1.0m−$2.0m
Free cash flow$17.0m$15.0m$19.0m−$1.0m$5.0m$22.0m$5.0m−$9.0m
Total assets$557.4m$547.4m$527.5m$510.2m$557.2m$536.6m$524.8m$527.7m
Cash and short-term investments$141.3m$138.6m$126.0m$109.4m$105.9m$101.7m$86.9m$85.7m
Debt$58.9m$67.8m$68.3m$69.0m$69.6m$72.9m$73.6m$74.1m
Shareholders' equity$235.6m$229.0m$256.8m$245.0m$235.0m$238.0m$248.5m$260.9m

Financial ratios

Data as of 5 Nov 2026

FY2026FY2025FY2024FY2023FY2022FY2021FY2019FY2018FY2017FY2016FY2015
Operating margin6.7%-1.9%-2.3%-7.2%-0.7%-2.9%—————
Net margin-0.3%-3.6%-2.8%-5.9%-0.9%-6.9%—————
Return on equity-1.1%-12.9%-7.9%-15.1%-2.0%-13.1%—————
Return on assets-0.5%-5.4%-3.7%-7.4%-1.2%-8.2%—————
Free cash flow yield5.9%2.9%-2.2%-2.2%4.9%0.9%—————
Revenue growth15.9%11.8%11.0%-1.5%9.5%12.4%—————
Earnings growth-91.6%42.1%-47.5%523.7%-85.2%-267.4%—————
Current ratio1.05x1.07x1.25x1.25x2.29x3.19x—————
Debt to equity0.25x0.30x0.27x0.29x0.22x0.22x—————
Equity ratio42.3%42.2%46.4%49.2%59.0%62.1%—————
Interest coverage15.57x-3.50x-4.42x-32.37x-1.87x-1.08x—————
R&D as a share of sales——————0.0%0.4%1.6%10.6%14.0%
Buybacks as a share of market value-0.5%-0.7%0.3%-0.2%-0.0%-1.7%—————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue12.9%9.2%105.5%
Operating income—-2.4%—
Net income-60.3%-43.5%-4.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin2.0%-1.1%0.7%1.9%
Net margin-1.8%-2.9%-3.1%-2.2%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021
Price to earnings-529.3-23.4-24.9-20.1-149.3-15.4
Price to sales1.40.80.71.21.41.1

Market value over time

31 Dec 2015 to 4 Nov 2026, in USD

$8.2m$1.34bn

Share price return

Finished calendar years

20252024202320222021
Return60%-30%-21%28%-66%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.